Topics in Lung Disease: Pulmonary Nodules

Area of Science:

• Pulmonology
• Radiology
• Oncology

Background:

• Pulmonary nodules are frequently detected via low-dose chest computed tomography (CT) for lung cancer screening or incidentally.
• Over 1.6 million individuals in the US are diagnosed annually, mostly asymptomatic, necessitating a structured evaluation approach.
• Lung cancer screening in high-risk individuals, as recommended by the US Preventive Services Task Force, is proven to reduce mortality.

Purpose of the Study:

• To outline the evaluation and management of pulmonary nodules.
• To highlight the importance of risk stratification for determining appropriate patient management.
• To discuss the roles of various guidelines and risk factors in nodule assessment.

Main Methods:

• Utilizing statistical models incorporating radiographic features and clinical history to estimate malignancy risk.
• Applying guidelines from the Fleischner Society for incidentally detected nodules and the Lung CT Screening Reporting and Data System (Lung-RADS) for risk stratification.
• Considering patient-specific risk factors such as smoking history, age, comorbidities, and exposure history.

Main Results:

• Radiographic indicators of malignancy include part-solid or ground-glass appearance, larger size, spiculated margins, vascular convergence, and pleural retraction.
• Key risk factors increasing malignancy probability include smoking history, advanced age, COPD, prior cancer, and toxin exposure.
• Management varies from serial imaging for low-risk nodules to invasive procedures like biopsy or resection for high-risk lesions.

Conclusions:

• A systematic approach integrating imaging findings, clinical history, and established guidelines is crucial for pulmonary nodule management.
• Risk stratification guides decisions between surveillance and intervention, optimizing patient outcomes.
• Referral to specialists is indicated for nodules with high malignancy potential or when tissue diagnosis is needed.